Common problems identified in audits by the U.S. Food and Drug Administration (FDA) include which of the following: A. Inadequate oversight at the Clinical Coordinating Center. B. Inadequate records that do not support the reported data. C. Inadequate study drug accountability. D. A and B E. B and C